Key result
Longitudinal increases in abdominal visceral fat were significantly associated with decreasing lung function (FEV1 and FVC), whereas decreases in visceral fat were related to improved lung function.
Why the study?
Do longitudinal changes in abdominal visceral obesity correlate with changes in lung function in asymptomatic non-smokers?
Population
1,145 asymptomatic non-smokers who underwent a comprehensive health evaluation including spirometry and…
Design
Cohort
Follow-up
mean 1,105 days (over 3.0 years)
Authors
Loading...
Visceral fat changes associate with lung function trajectories in non-smokers; hypothesis-generating for targeted obesity interventions before practice change.
Cohort (n=1,145)
No
Do longitudinal changes in abdominal visceral obesity correlate with changes in lung function in asymptomatic non-smokers?
p-value: p=<0.05
Decreasing abdominal visceral obesity is associated with improved lung function in asymptomatic non-smokers, suggesting respiratory benefits from visceral fat reduction.
Choe et al. (2018) conducted a cohort in Asymptomatic non-smokers (n=1,145). Changes in abdominal visceral obesity vs. No change in adiposity was evaluated on Changes in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) (p=<0.05). Longitudinal increases in abdominal visceral fat were significantly associated with decreasing lung function (FEV1 and FVC), whereas decreases in visceral fat were related to improved lung function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: